Complete Filing Data
Ovid Therapeutics Inc. reported Net Income Loss of -$17.41 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Ovid Therapeutics Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $7.3M | $566.0K | $392.0K | $1.5M | $208.4M | $12.6M | |||||
| Net Income Loss | -$17.4M | -$26.4M | -$52.3M | -$54.2M | $122.8M | -$81.0M | -$60.5M | -$52.0M | -$64.8M | -$22.4M | -$13.2M |
| Operating Expenses | $49.7M | $62.5M | $59.7M | $57.1M | $84.2M | $94.0M | $61.4M | $52.9M | $65.0M | $22.5M | $13.2M |
| Research And Development Expense | $25.6M | $36.8M | $28.6M | $24.6M | $46.9M | $63.4M | $42.2M | $33.8M | $50.0M | $9.6M | $6.6M |
| Operating Income Loss | -$42.4M | -$61.9M | -$59.3M | -$55.5M | $124.2M | -$81.4M | -$61.4M | -$52.9M | -$65.0M | -$22.5M | -$13.2M |
| General And Administrative Expense | $24.1M | $25.7M | $31.1M | $32.4M | $37.2M | $30.6M | $19.3M | $19.1M | $15.0M | $12.9M | $6.6M |
| Comprehensive Income Net Of Tax | -$17.6M | -$26.5M | -$52.3M | -$54.2M | $122.8M | -$81.0M | -$60.5M | -$52.0M | -$64.8M | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$27.0K | $7.0K | $1.0K | -$42.2K | $0.00 | -$2.5K | $4.3K | -$1.8K | |||
| Net Income Loss Available To Common Stockholders Basic | $119.8M | -$81.0M | -$60.5M | -$52.0M | -$64.8M | -$22.4M | -$13.2M | ||||
| Nonoperating Income Expense | $948.2K | $952.1K | $201.5K | $120.8K | $30.3K | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$17.4M | -$26.4M | -$52.3M | -$54.2M | $124.2M | -$81.0M | |||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $1.3M | $0.00 | |||||
| Other Comprehensive Income Loss Before Tax Portion Attributable To Parent | -$167.0K | -$36.0K | $43.0K | -$42.2K | |||||||
| Other Nonoperating Income Expense | $25.0M | $35.5M | $6.9M | $1.4M | -$45.7K | ||||||
| Other Comprehensive Income Loss Net Of Tax | -$2.5K | $4.3K | -$1.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $132.0K | $6.3M | $130.0K | $173.0K | $169.0K | $148.0K | $109.0K | $75.0K | $66.0K | $11.1K | $0.00 | $1.4M | $0.00 | $0.00 | $208.4M | $6.9M | ||||||||||||||||||
| Net Income Loss | -$12.2M | -$4.7M | -$10.2M | -$14.0M | $8.5M | -$11.7M | -$11.3M | -$12.4M | -$13.4M | -$12.0M | -$14.6M | -$16.1M | -$11.4M | -$15.8M | $176.0M | -$16.4M | -$22.6M | -$20.0M | -$17.0M | -$16.6M | -$13.1M | -$13.8M | -$12.9M | -$13.0M | -$12.9M | -$13.2M | -$11.0M | -$9.4M | -$10.2M | -$34.2M | -$7.6M | -$5.8M | -$5.4M | -$3.7M |
| Operating Expenses | $12.7M | $11.3M | $12.7M | $13.4M | $20.7M | $17.6M | $12.1M | $14.2M | $15.0M | $12.8M | $14.3M | $17.7M | $11.7M | $14.3M | $31.8M | $23.3M | $23.1M | $20.3M | $17.3M | $16.8M | $13.3M | $14.1M | $13.1M | $13.2M | $13.2M | $13.4M | $11.0M | $9.4M | $10.3M | $34.3M | $7.6M | $5.8M | $5.4M | $3.7M |
| Research And Development Expense | $5.9M | $6.5M | $6.7M | $7.9M | $12.6M | $10.4M | $5.3M | $6.0M | $6.6M | $5.2M | $6.0M | $7.8M | $4.9M | $7.7M | $16.2M | $15.9M | $16.0M | $14.6M | $11.6M | $9.1M | $9.3M | $8.5M | $8.1M | $8.5M | $5.9M | $6.1M | $31.3M | $2.7M | $1.8M | $1.1M | ||||
| Operating Income Loss | -$12.5M | -$5.1M | -$12.6M | -$13.2M | -$20.5M | -$17.4M | -$12.0M | -$14.2M | -$14.9M | -$12.8M | -$14.3M | -$16.3M | -$11.7M | -$14.3M | $176.6M | -$16.4M | -$23.1M | -$20.3M | -$16.8M | -$13.3M | -$14.1M | -$13.2M | -$13.2M | -$13.4M | -$9.4M | -$10.3M | -$34.3M | -$5.8M | -$5.4M | |||||
| General And Administrative Expense | $6.8M | $4.9M | $6.0M | $5.5M | $8.1M | $7.2M | $6.8M | $8.2M | $8.3M | $7.6M | $8.3M | $9.9M | $6.8M | $6.6M | $15.6M | $7.4M | $7.1M | $5.7M | $5.2M | $4.2M | $4.7M | $4.6M | $5.1M | $5.0M | $3.5M | $4.2M | $3.0M | $3.1M | $3.6M | |||||
| Comprehensive Income Net Of Tax | -$12.2M | -$4.7M | -$10.2M | -$14.0M | $8.5M | -$11.7M | -$11.3M | -$12.4M | -$13.3M | -$12.0M | -$14.7M | -$16.1M | -$11.4M | -$15.8M | $176.0M | -$16.4M | -$22.6M | -$20.0M | -$16.6M | -$13.1M | -$13.8M | -$13.0M | -$12.9M | -$13.2M | -$9.4M | -$10.2M | -$34.2M | |||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $3.0K | -$1.0K | -$2.0K | $48.0K | $7.0K | -$20.0K | -$9.0K | $0.00 | $48.0K | $7.3K | -$90.1K | $0.00 | $0.00 | $0.00 | -$65.7K | $63.2K | -$1.4K | $3.2K | $11.3K | $19.9K | -$35.9K | |||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$16.4M | -$22.6M | -$20.0M | -$17.0M | -$16.6M | -$13.1M | -$13.8M | -$12.9M | -$13.0M | -$12.9M | -$13.2M | -$11.0M | -$9.4M | -$10.2M | -$34.2M | -$7.6M | -$5.8M | -$5.4M | -$3.7M | |||||||||||||||
| Nonoperating Income Expense | $590.5K | $264.3K | $299.0K | $131.0K | $265.0K | $253.3K | $216.0K | $214.0K | $275.0K | $247.0K | $88.0K | $51.0K | $40.0K | $23.0K | $27.0K | $30.0K | $31.0K | $32.0K | ||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$12.2M | -$4.7M | -$10.2M | -$14.0M | $8.5M | -$11.7M | -$11.3M | -$12.4M | -$13.4M | -$12.0M | -$14.6M | -$16.1M | -$11.7M | -$14.3M | $176.5M | -$16.4M | -$22.6M | -$20.0M | -$34.2M | -$3.7M | ||||||||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $50.0K | -$294.8K | $1.5M | $500.3K | $0.00 | $0.00 | |||||||||||||||||
| Other Comprehensive Income Loss Before Tax Portion Attributable To Parent | -$57.0K | -$22.0K | -$12.0K | $48.0K | $7.0K | -$20.0K | -$9.0K | $0.00 | $48.0K | $7.3K | -$90.1K | |||||||||||||||||||||||
| Other Nonoperating Income Expense | $365.0K | $389.0K | $2.3M | -$780.0K | $29.0M | $5.7M | $776.0K | $1.8M | $1.5M | $836.1K | -$284.1K | $209.1K | ||||||||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax | -$65.7K | $63.2K | -$1.4K | $3.2K | $11.3K | $19.9K | -$35.9K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $130.7M | $68.2M | $87.8M | $132.3M | $179.7M | $43.6M | $70.0M | $38.8M | $83.4M | $49.3M | $68.1M | $4.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $15.1M | $28.2M | $29.0M | $46.8M | $189.7M | $72.0M | $41.9M | $36.5M | $87.1M | |||
| Cash And Cash Equivalents At Carrying Value | $13.2M | $26.3M | $27.0M | $44.9M | $187.8M | $72.0M | $41.9M | $36.5M | $51.9M | $69.9M | $4.8M | |
| Retained Earnings Accumulated Deficit | -$321.7M | -$304.3M | -$277.9M | -$225.5M | -$171.4M | -$294.2M | -$213.2M | -$152.7M | -$100.7M | -$35.9M | ||
| Property Plant And Equipment Net | $252.0K | $433.0K | $769.0K | $1.1M | $242.8K | $135.6K | $68.4K | $69.9K | $51.8K | $43.6K | ||
| Prepaid Expense And Other Assets Current | $4.7M | $2.9M | $3.8M | $2.4M | $2.7M | $2.7M | $1.9M | $2.2M | $1.5M | $221.5K | ||
| Other Assets Noncurrent | $0.00 | $92.0K | $210.0K | $261.2K | $260.1K | $318.9K | $467.2K | $391.9K | $124.2K | $165.3K | ||
| Liabilities And Stockholders Equity | $150.9M | $92.2M | $144.0M | $155.3M | $194.5M | $75.9M | $80.8M | $47.6M | $89.5M | $53.0M | ||
| Common Stock Value | $130.0K | $71.0K | $71.0K | $70.5K | $70.4K | $65.7K | $54.7K | $24.7K | $24.6K | $9.8K | ||
| Assets Current | $74.4M | $55.9M | $109.6M | $131.4M | $190.5M | $74.8M | $79.8M | $44.3M | $88.6M | $52.4M | ||
| Assets | $150.9M | $92.2M | $144.0M | $155.3M | $194.5M | $75.9M | $80.8M | $47.6M | $89.5M | $53.0M | ||
| Accrued Liabilities Current | $4.9M | $6.0M | $6.5M | $4.5M | $7.7M | $12.0M | $7.3M | $5.1M | $4.0M | $2.9M | ||
| Accounts Payable Current | $2.0M | $3.2M | $3.7M | $2.0M | $7.1M | $5.4M | $3.3M | $3.8M | $2.0M | $857.2K | ||
| Liabilities Current | $8.3M | $10.5M | $11.5M | $7.0M | $14.8M | $22.1M | $10.5M | $8.8M | $6.0M | $3.7M | ||
| Liabilities | $20.3M | $23.9M | $56.2M | $23.0M | $14.8M | $32.3M | $10.8M | $8.8M | ||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $1.00 | $1.00 | $3.00 | $8.00 | |||||
| Available For Sale Securities Debt Securities Current | $56.5M | $26.8M | $78.8M | $84.1M | $0.00 | $34.8M | $5.0M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$202.0K | -$35.0K | $1.0K | -$42.2K | $0.00 | $2.5K | -$1.8K | |||||
| Additional Paid In Capital Common Stock | $337.8M | $283.1M | $191.5M | $184.1M | ||||||||
| Restricted Cash | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $0.00 | ||||||
| Long Term Investments | $17.6M | $5.6M | $1.6M | $0.00 | ||||||||
| Operating Lease Right Of Use Asset | $11.6M | $12.8M | $13.9M | $14.9M | $0.00 | |||||||
| Equity Securities Fv Ni Unrealized Gain Loss | $21.1M | $3.3M | $2.0M | -$454.8K | $0.00 | |||||||
| Operating Lease Right Of Use Asset Amortization Expense | $1.2M | $1.1M | $1.0M | $869.1K | $0.00 | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$13.1M | -$740.0K | -$142.9M | $117.7M | $30.1M | $5.4M | -$50.6M | |||||
| Preferred Stock Share Designated | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | |||||||
| Operating Lease Liability Noncurrent | $12.0M | $13.4M | $14.8M | $16.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $44.7M | $55.8M | $59.3M | $76.3M | $88.9M | $78.3M | $101.3M | $110.7M | $120.9M | $142.1M | $152.1M | $165.0M | $197.0M | $206.7M | $221.1M | $63.6M | $30.5M | $51.4M | $30.0M | $45.4M | $57.2M | $50.0M | $61.1M | $72.1M | $93.0M | $100.9M | $42.3M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $22.5M | $30.3M | $23.1M | $16.9M | $31.6M | $32.7M | $59.4M | $73.6M | $65.0M | $60.2M | $74.7M | $168.6M | $201.8M | $212.2M | $233.1M | $86.9M | $41.3M | $27.3M | $37.9M | $47.4M | $54.6M | $30.5M | |||||||||||
| Cash And Cash Equivalents At Carrying Value | $20.6M | $28.4M | $21.1M | $15.0M | $29.7M | $30.8M | $57.4M | $71.6M | $63.1M | $58.3M | $72.8M | $166.7M | $201.8M | $212.2M | $233.1M | $86.9M | $41.3M | $27.3M | $37.9M | $47.4M | $54.6M | $30.5M | $22.5M | $29.2M | $87.1M | $96.0M | $106.1M | $44.2M | $57.8M | $62.5M | $66.0M | ||
| Retained Earnings Accumulated Deficit | -$331.4M | -$319.2M | -$314.5M | -$295.0M | -$281.0M | -$289.6M | -$262.5M | -$251.3M | -$238.9M | -$214.0M | -$202.1M | -$187.5M | -$145.4M | -$134.0M | -$118.2M | -$272.2M | -$255.7M | -$233.2M | -$196.2M | -$179.6M | -$166.5M | -$139.8M | -$126.8M | -$113.9M | -$89.8M | -$80.4M | -$70.1M | ||||||
| Property Plant And Equipment Net | $269.0K | $285.0K | $346.0K | $509.0K | $618.0K | $686.0K | $856.5K | $955.6K | $1.1M | $1.2M | $1.2M | $257.9K | $104.7K | $113.7K | $128.5K | $137.8K | $116.0K | $109.0K | $72.2K | $58.8K | $66.2K | $68.2K | $67.7K | $52.1K | $51.7K | $49.8K | $46.6K | ||||||
| Prepaid Expense And Other Assets Current | $3.2M | $3.7M | $2.9M | $3.1M | $3.9M | $2.9M | $4.6M | $5.7M | $1.8M | $2.6M | $2.7M | $2.4M | $3.3M | $3.7M | $2.6M | $2.8M | $2.3M | $2.0M | $1.2M | $4.7M | $1.9M | $2.7M | $2.6M | $1.5M | $827.9K | $1.2M | $389.4K | ||||||
| Other Assets Noncurrent | $0.00 | $0.00 | $39.0K | $182.0K | $246.0K | $174.0K | $248.7K | $290.0K | $212.5K | $275.4K | $328.8K | $244.0K | $197.1K | $227.4K | $262.8K | $361.0K | $375.8K | $436.3K | $351.3K | $270.9K | $331.1K | $406.1K | $313.3K | $160.4K | $207.7K | $215.7K | $200.3K | ||||||
| Liabilities And Stockholders Equity | $63.8M | $77.4M | $81.7M | $102.7M | $118.1M | $131.6M | $125.0M | $136.2M | $143.4M | $165.0M | $177.3M | $191.1M | $207.1M | $218.0M | $237.5M | $91.6M | $45.4M | $61.7M | $40.7M | $54.9M | $66.7M | $60.4M | $68.6M | $78.7M | $97.6M | $108.0M | $47.2M | ||||||
| Common Stock Value | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $70.7K | $70.6K | $70.5K | $70.5K | $70.4K | $70.4K | $68.0K | $67.8K | $67.8K | $63.4K | $57.1K | $54.8K | $37.5K | $38.7K | $38.7K | $24.7K | $24.6K | $24.6K | $24.6K | $24.6K | $9.8K | ||||||
| Assets Current | $28.8M | $42.1M | $45.9M | $65.8M | $80.9M | $93.2M | $91.7M | $102.2M | $119.5M | $140.5M | $156.1M | $170.1M | $205.1M | $215.9M | $236.7M | $90.3M | $44.1M | $60.7M | $39.2M | $53.6M | $62.8M | $55.3M | $65.2M | $75.7M | $96.9M | $107.3M | $46.5M | ||||||
| Assets | $63.8M | $77.4M | $81.7M | $102.7M | $118.1M | $131.6M | $125.0M | $136.2M | $143.4M | $165.0M | $177.3M | $191.1M | $207.1M | $218.0M | $237.5M | $91.6M | $45.4M | $61.7M | $40.7M | $54.9M | $66.7M | $60.4M | $68.6M | $78.7M | $97.6M | $108.0M | $47.2M | ||||||
| Accrued Liabilities Current | $3.0M | $2.9M | $6.0M | $7.6M | $8.1M | $4.0M | $6.2M | $5.4M | $4.1M | $5.7M | $4.6M | $8.0M | $6.9M | $10.4M | $13.2M | $11.4M | $9.9M | $6.0M | $4.7M | $7.1M | $3.7M | $5.8M | $4.1M | $4.2M | $3.2M | $3.5M | $3.3M | ||||||
| Accounts Payable Current | $1.7M | $4.0M | $2.0M | $2.7M | $4.7M | $3.6M | $1.2M | $3.8M | $1.8M | $1.0M | $4.6M | $2.3M | $3.1M | $909.5K | $3.1M | $3.2M | $4.6M | $4.0M | $5.3M | $2.0M | $4.4M | $4.6M | $3.4M | $2.4M | $1.5M | $3.6M | $1.6M | ||||||
| Liabilities Current | $6.8M | $8.9M | $9.3M | $11.6M | $14.1M | $8.9M | $8.7M | $10.1M | $6.7M | $10.1M | $11.3M | $16.3M | $18.0M | $14.6M | $10.0M | $10.4M | $9.2M | $8.1M | $10.4M | $7.5M | $6.6M | $4.6M | $7.1M | $4.9M | |||||||||
| Liabilities | $19.2M | $21.6M | $22.4M | $26.4M | $29.2M | $53.3M | $23.7M | $25.5M | $22.4M | $23.0M | $25.2M | $26.1M | $10.1M | $11.3M | $16.3M | $28.0M | $14.9M | $10.3M | $10.6M | $9.5M | $9.4M | ||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $6.00 | $6.00 | $8.00 | $4.00 | $3.00 | $3.00 | ||||||||||||
| Available For Sale Securities Debt Securities Current | $5.0M | $9.9M | $21.9M | $47.7M | $47.3M | $59.5M | $29.6M | $24.9M | $54.7M | $79.6M | $79.6M | $31.0M | $5.0M | $22.0M | $40.1M | $45.0M | |||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$126.0K | -$69.0K | -$47.0K | $36.0K | -$12.0K | -$19.0K | -$3.9K | $5.2K | $5.6K | -$82.8K | -$90.1K | $65.7K | $1.4K | -$4.7K | -$16.0K | -$35.9K | |||||||||||||||||
| Additional Paid In Capital Common Stock | $356.1M | $354.2M | $352.4M | $351.0M | $342.3M | $340.6M | $339.2M | $335.7M | $286.2M | $284.5M | $226.2M | $225.0M | $223.7M | $189.7M | $187.9M | $186.0M | |||||||||||||||||
| Restricted Cash | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | |||||||||||||||||||||
| Long Term Investments | $20.9M | $20.9M | $20.9M | $21.0M | $21.1M | $21.1M | $22.0M | $16.1M | $16.5M | $6.0M | $6.0M | $2.2M | $2.8M | $1.6M | $1.6M | ||||||||||||||||||
| Operating Lease Right Of Use Asset | $11.9M | $12.2M | $12.5M | $13.1M | $13.4M | $13.6M | $14.2M | $14.4M | $14.7M | $15.2M | $15.4M | $15.7M | |||||||||||||||||||||
| Equity Securities Fv Ni Unrealized Gain Loss | -$66.0K | $4.4M | $360.0K | $207.1K | $0.00 | ||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $288.0K | $266.0K | $253.0K | $0.00 | |||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$21.1M | $161.0M | -$14.6M | $18.1M | |||||||||||||||||||||||||||||
| Preferred Stock Share Designated | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | ||||||||||||||||||||||||
| Operating Lease Liability Noncurrent | $12.4M | $12.7M | $13.1M | $13.8M | $14.1M | $14.4M | $15.1M | $15.4M | $15.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $75.2M | $622.0K | $30.5M | $180.7K | $904.1K | $47.1M | $86.5M | $286.1K | $66.7M | -$13.7K | $70.6M |
| Investing Cash Flow * | -$49.9M | $54.6M | -$2.6M | -$87.9M | -$1.8M | $34.6M | -$30.0M | -$5.4M | -$47.4K | -$189.0K | -$56.3K |
| Operating Cash Flow * | -$38.3M | -$56.0M | -$45.8M | -$55.2M | $118.6M | -$51.6M | -$51.1M | -$45.6M | -$31.5M | -$17.8M | -$5.5M |
| Share Based Compensation | $4.8M | $6.3M | $7.3M | $6.6M | $5.1M | $7.5M | $5.2M | $7.1M | $6.4M | $3.6M | $1.5M |
| Payments To Acquire Property Plant And Equipment | $0.00 | $71.0K | $40.0K | $1.2M | $184.0K | $127.2K | $57.2K | $33.9K | $38.9K | $30.4K | $32.1K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.8M | -$899.0K | $1.4M | -$109.3K | -$40.5K | -$724.6K | -$224.5K | $1.3M | $793.3K | -$58.8K | $279.6K |
| Increase Decrease In Accrued Liabilities | -$1.1M | -$537.0K | $2.0M | -$3.2M | -$4.4M | $4.8M | $2.2M | $1.1M | $1.1M | $1.2M | $1.6M |
| Increase Decrease In Accounts Payable Trade | -$1.2M | -$512.0K | $1.8M | -$5.2M | $1.7M | $2.3M | -$654.0K | $1.6M | $1.1M | $186.6K | $591.4K |
| Depreciation Depletion And Amortization | $273.0K | $613.0K | $568.0K | $512.5K | $237.1K | $306.8K | $255.0K | $141.7K | $80.3K | $56.5K | $11.8K |
| Proceeds From Stock Options Exercised | $91.0K | $622.0K | $535.0K | $180.7K | $925.4K | $300.8K | $111.4K | $27.0K | |||
| Payments To Acquire Available For Sale Securities Debt | $91.9M | $73.2M | $112.4M | $173.0M | $0.00 | $10.0M | $34.8M | $50.0M | |||
| Payments To Develop Software | $0.00 | $90.0K | $97.0K | $194.4K | $5.4K | $263.4K | $186.9K | $318.1K | |||
| Increase Decrease In Security Deposits | $54.6K | -$15.2K | -$13.2K | -$33.2K | -$36.6K | -$362.9K | -$38.3K | ||||
| Increase Decrease In Prepaid Expense Noncurrent | $0.00 | -$477.2K | -$117.6K | -$2.4M | $2.2M | $604.6K | |||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $42.0M | $128.0M | $120.0M | $90.0M | $0.00 | ||||||
| Proceeds From Stock Plans | $118.2K | $203.5K | $131.9K | $174.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $13.0K | $228.0K | $67.0K | $33.1K | $129.7K | $15.5K | $31.0M | $75.4K | -$505.2K | -$36.3K |
| Investing Cash Flow * | $5.1M | $20.2M | $30.2M | -$1.1M | -$11.5K | $3.8M | -$9.0K | -$45.1M | -$52.6K | -$28.2K |
| Operating Cash Flow * | -$10.3M | -$16.7M | -$12.1M | -$20.1M | $160.9M | -$18.4M | -$12.9M | -$12.9M | -$7.2M | -$3.8M |
| Share Based Compensation | $1.3M | $2.0M | $1.9M | $1.3M | $1.3M | $1.3M | $1.6M | $1.8M | $1.4M | $721.0K |
| Payments To Acquire Property Plant And Equipment | $0.00 | $19.0K | $14.0K | $45.9K | $11.5K | $14.1K | $4.3K | $7.6K | $12.1K | $14.7K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $60.0K | -$853.0K | -$258.0K | -$262.4K | -$80.4K | $86.8K | -$242.3K | $67.2K | $167.9K | -$160.6K |
| Increase Decrease In Accrued Liabilities | -$1.0K | -$2.5M | -$419.0K | $299.3K | $1.2M | -$1.3M | -$1.4M | $187.0K | $411.7K | -$695.9K |
| Increase Decrease In Accounts Payable Trade | -$1.2M | -$107.0K | -$121.0K | -$4.9M | -$2.3M | $932.0K | $264.1K | $365.5K | $718.8K | $149.1K |
| Depreciation Depletion And Amortization | $141.0K | $136.0K | $145.0K | $73.8K | $74.7K | $66.9K | $76.5K | $26.4K | $18.5K | $5.9K |
| Proceeds From Stock Options Exercised | $13.0K | $228.0K | $67.0K | $33.1K | $20.8K | $12.7K | ||||
| Payments To Acquire Available For Sale Securities Debt | $4.9M | $9.8M | $9.8M | $0.00 | $10.0M | $45.0M | ||||
| Payments To Develop Software | $0.00 | $30.2K | $0.00 | $188.8K | $4.7K | |||||
| Increase Decrease In Security Deposits | -$4.3K | $0.00 | -$18.4K | -$1.1K | -$39.5K | -$7.5K | ||||
| Increase Decrease In Prepaid Expense Noncurrent | $0.00 | -$225.1K | -$73.0K | $514.0K | $2.0M | |||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $10.0M | $30.0M | $40.0M | $0.00 | ||||||
| Proceeds From Stock Plans | $0.00 | $130.2K | $83.1K | $73.1K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.74 | -$0.77 | $1.76 | -$1.39 | -$2.11 | -$3.35 | -$2.28 | -$1.36 | |||
| Common Stock Shares Authorized | 315.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 58.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 130.2M | 71.0M | 70.7M | 70.5M | 70.4M | 65.7M | 54.7M | 24.7M | 24.6M | 9.8M | |
| Common Stock Shares Issued | 130.2M | 71.0M | 70.7M | 70.5M | 70.4M | 65.7M | 54.7M | 24.7M | 24.6M | 9.8M | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 70.6M | 70.4M | 67.5M | 58.5M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 70.6M | 70.4M | 68.1M | 58.5M | |||||||
| Earnings Per Share Basic | $-0.74 | $-0.77 | $1.78 | $-1.39 | |||||||
| Preferred Stock Shares Outstanding | 0.00 | 1.3K | 1.3K | 1.3K | 1.3K | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 1.3K | 1.3K | 1.3K | 1.3K | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.20 | $0.12 | -$0.17 | -$0.16 | -$0.18 | -$0.19 | -$0.17 | -$0.21 | -$0.23 | -$0.17 | -$0.23 | $2.53 | -$0.28 | -$0.41 | -$0.37 | -$0.35 | -$0.43 | -$0.34 | -$0.46 | -$0.52 | -$0.53 | -$0.53 | -$0.54 | -$0.45 | -$0.38 | -$0.57 | -$3.48 | -$0.77 | -$0.59 | -$0.55 | -$0.37 | ||||
| Common Stock Shares Authorized | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | 62.0M | 1.0K | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Common Stock Shares Outstanding | 71.2M | 71.1M | 71.1M | 71.0M | 71.0M | 70.8M | 70.7M | 70.6M | 70.5M | 70.5M | 70.4M | 70.4M | 68.0M | 67.8M | 67.8M | 63.4M | 57.1M | 54.8M | 37.5M | 38.7M | 38.7M | 24.7M | 24.6M | 24.6M | 24.6M | 24.6M | 9.8M | ||||||||
| Common Stock Shares Issued | 71.2M | 71.1M | 71.1M | 71.0M | 71.0M | 70.8M | 70.7M | 70.6M | 70.5M | 70.5M | 70.4M | 70.4M | 68.0M | 67.8M | 67.8M | 63.4M | 57.1M | 54.8M | 37.5M | 38.7M | 38.7M | 24.7M | 24.6M | 24.6M | 24.6M | 24.6M | 9.8M | ||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 71.0M | 70.9M | 70.7M | 70.6M | 70.5M | 70.5M | 70.4M | 70.4M | 70.3M | 67.9M | 67.8M | 66.1M | 59.4M | 55.6M | 54.7M | ||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 71.0M | 71.2M | 70.7M | 70.6M | 70.5M | 70.5M | 70.4M | 70.4M | 70.3M | 67.9M | 67.8M | 66.6M | 59.4M | 55.6M | 54.7M | ||||||||||||||||||||
| Earnings Per Share Basic | $-0.20 | $0.12 | $-0.17 | $-0.16 | $-0.18 | $-0.19 | $-0.17 | $-0.21 | $-0.23 | $-0.17 | $-0.23 | $2.55 | $-0.28 | $-0.41 | $-0.37 | ||||||||||||||||||||
| Preferred Stock Shares Outstanding | 1.3K | 1.3K | 1.3K | 1.3K | 1.3K | 1.3K | 1.3K | 1.3K | 1.3K | 0.00 | 0.00 | ||||||||||||||||||||||||
| Preferred Stock Shares Issued | 1.3K | 1.3K | 1.3K | 1.3K | 1.3K | 1.3K | 1.3K | 1.3K | 1.3K | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.8M | $6.3M | $7.3M | $6.6M | $5.1M | $7.5M | $5.2M | $7.1M | $6.4M | $3.6M | $1.5M |
| Stock Issued During Period Value Employee Stock Purchase Plan | $91.0K | $622.0K | $535.0K | $180.7K | $925.7K | $203.5K | $131.9K | $174.8K | |||
| Security Deposit | $150.6K | $135.4K | $122.2K | $88.9K | $407.8K | ||||||
| Additional Paid In Capital | $452.4M | $372.5M | $365.6M | $357.8M | $351.0M | $184.1M | $85.2M | ||||
| Stock Issued During Period Value Stock Options Exercised | $807.5K | $300.8K | $111.4K | $27.0K | |||||||
| Prepaid Expense Noncurrent | $0.00 | $477.2K | $359.5K | $2.8M | $604.6K | ||||||
| Other Operating Income Expense Net | -$45.7K | $395.4K | $948.2K | ||||||||
| Increase Decrease Due From Affiliates | $0.00 | -$141.8K | $989.4K | $531.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.1M | $1.2M | $1.3M | $1.3M | $1.7M | $2.0M | $1.6M | $1.9M | $1.9M | $1.8M | $1.7M | $1.3M | $1.2M | $1.3M | $1.3M | $2.6M | $1.6M | $1.3M | $1.2M | $1.3M | $1.6M | $1.7M | $1.8M | $1.8M | $1.4M | |||
| Stock Issued During Period Value Employee Stock Purchase Plan | $15.0K | $0.00 | $13.0K | $37.0K | $356.0K | $228.0K | $224.0K | $211.0K | $67.0K | $81.6K | $109.5K | $33.1K | $74.5K | $130.2K | $120.4K | $83.1K | $58.8K | $73.1K | $112.0K | $62.7K | ||||||||
| Security Deposit | $39.1K | $80.1K | $100.3K | $96.0K | $96.0K | $177.7K | $150.6K | $154.4K | $153.8K | $153.8K | $113.6K | $113.6K | $123.3K | $121.9K | $121.9K | $128.4K | $437.0K | $430.3K | $415.3K | |||||||||
| Additional Paid In Capital | $376.1M | $375.0M | $373.8M | $371.2M | $369.9M | $367.8M | $363.8M | $361.9M | $359.8M | $182.7M | $181.3M | $112.5M | ||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $81.6K | $109.5K | $33.1K | $534.6K | $130.7K | $151.0K | $116.9K | $160.9K | $98.7K | $12.7K | ||||||||||||||||||
| Prepaid Expense Noncurrent | $252.1K | $599.0K | $599.0K | $286.6K | $1.0M | $857.9K | $3.3M | $4.5M | $2.9M | $2.6M | ||||||||||||||||||
| Other Operating Income Expense Net | $836.1K | -$284.1K | $209.1K | $2.7K | -$2.5K | -$49.7K | -$21.1K | $590.5K | $264.3K | $131.2K | ||||||||||||||||||
| Increase Decrease Due From Affiliates | $0.00 | $882.0K | -$756.9K | $657.5K |
Most recent annual filing with the SEC: March 18, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.